|
|
Our proprietary product development portfolio covers two distinct areas of clinical
need:
AeroVax™ for Aerosol Delivery of Vaccines
AeroCell™ for Respiratory Delivery of Therapeutics
|
The Company’s lead product candidates are
known molecules and biologics and thus offer
reduced development risks, cost efficient
development plans, and leverage established
clinical development routes. Our goal simply stated
is to deliver the right therapy to the right place at
the right time, and our nebulizer device has the
flexibility to target therapeutics to the nasal cavity
and the upper or lower airways.
|
|
|
